Director's dealing

RNS Number : 7675G
Avacta Group PLC
09 May 2014
 



 

Avacta Group plc

("Avacta" or the "Group")

 

Director's dealing

 

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces that Craig Slater, Chief Operating Officer of the Group, has today purchased 641,025 Ordinary Shares of 0.1p each in the Group at a price of 1.17 pence per share.

 

Following this transaction, Mr Slater's total interest in the Group is 34,723,111 Ordinary Shares of 0.1p each, representing approximately 0.9% of Avacta's issued share capital.

 

Enquiries:

 

Avacta Group plc

Tel:  +44 (0) 844 414 0452

Alastair Smith, Chief Executive Officer

www.avacta.com

Tim Sykes, Chief Financial Officer




Numis Securities Limited

Tel:  +44 (0) 207 260 1000

Michael Meade / Freddie Barnfield - Nominated Adviser

www.numiscorp.com

James Black - Corporate Broking




Walbrook PR Ltd

   Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com

Anna Dunphy

                                                        Mob: +44 (0)7876 741 001

Lianne Cawthorne

Mob: +44 (0)7584 391 303

 

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

 

Avacta Analytical

www.avactaanalytical.com

 

High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.

Avacta Animal Health

www.avactaanimalhealth.com

 

Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLEEEIAIIS
UK 100

Latest directors dealings